DE60228732D1 - Mittel zur regulierung der sekretion von pankreassaft mit einem lpa-rezeptor-regler - Google Patents
Mittel zur regulierung der sekretion von pankreassaft mit einem lpa-rezeptor-reglerInfo
- Publication number
- DE60228732D1 DE60228732D1 DE60228732T DE60228732T DE60228732D1 DE 60228732 D1 DE60228732 D1 DE 60228732D1 DE 60228732 T DE60228732 T DE 60228732T DE 60228732 T DE60228732 T DE 60228732T DE 60228732 D1 DE60228732 D1 DE 60228732D1
- Authority
- DE
- Germany
- Prior art keywords
- pancreatic juice
- secretion
- regulating
- medium
- lpa receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000001819 pancreatic juice Anatomy 0.000 title abstract 4
- 230000028327 secretion Effects 0.000 title abstract 3
- 108091006073 receptor regulators Proteins 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 abstract 3
- 102000004137 Lysophosphatidic Acid Receptors Human genes 0.000 abstract 1
- 108090000642 Lysophosphatidic Acid Receptors Proteins 0.000 abstract 1
- 241000700157 Rattus norvegicus Species 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 230000001539 anorectic effect Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 239000008141 laxative Substances 0.000 abstract 1
- 230000002475 laxative effect Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001216133 | 2001-07-17 | ||
| PCT/JP2002/007213 WO2003007991A1 (fr) | 2001-07-17 | 2002-07-16 | Regulateurs de la secretion de suc pancreatique comprenant un agent de regulation du recepteur a lpa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60228732D1 true DE60228732D1 (de) | 2008-10-16 |
Family
ID=19050646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60228732T Expired - Fee Related DE60228732D1 (de) | 2001-07-17 | 2002-07-16 | Mittel zur regulierung der sekretion von pankreassaft mit einem lpa-rezeptor-regler |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20040171582A1 (de) |
| EP (1) | EP1415667B1 (de) |
| JP (1) | JPWO2003007991A1 (de) |
| AT (1) | ATE406915T1 (de) |
| DE (1) | DE60228732D1 (de) |
| ES (1) | ES2312588T3 (de) |
| WO (1) | WO2003007991A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050113283A1 (en) * | 2002-01-18 | 2005-05-26 | David Solow-Cordero | Methods of treating conditions associated with an EDG-4 receptor |
| JPWO2004002530A1 (ja) * | 2002-06-26 | 2005-10-27 | 小野薬品工業株式会社 | 慢性疾患治療剤 |
| EP2565178A1 (de) | 2002-10-03 | 2013-03-06 | Ono Pharmaceutical Co., Ltd. | LPA-Rezeptorantagonisten |
| JP4692281B2 (ja) * | 2003-08-05 | 2011-06-01 | 味の素株式会社 | 新規アゾール化合物 |
| JP4779650B2 (ja) * | 2003-12-26 | 2011-09-28 | 小野薬品工業株式会社 | 高活性型リゾホスファチジン酸およびそれを用いたスクリーニング方法 |
| US20090068281A1 (en) * | 2005-03-29 | 2009-03-12 | Koji Toyomura | Composition, Functional Food and Pharmaceutical Composition for Improvement in Obesity |
| WO2009082491A1 (en) * | 2007-12-26 | 2009-07-02 | Alp Life Sciences, Llc | Nanovesontm: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases |
| US8802706B2 (en) * | 2008-08-07 | 2014-08-12 | Nagasaki University | Method for treating fibromyalgia |
| WO2010068775A2 (en) | 2008-12-11 | 2010-06-17 | Amira Pharmaceuticals, Inc. | Alkyne antagonists of lysophosphatidic acid receptors |
| GB2466121B (en) * | 2008-12-15 | 2010-12-08 | Amira Pharmaceuticals Inc | Antagonists of lysophosphatidic acid receptors |
| GB2470833B (en) | 2009-06-03 | 2011-06-01 | Amira Pharmaceuticals Inc | Polycyclic antagonists of lysophosphatidic acid receptors |
| WO2011017350A2 (en) | 2009-08-04 | 2011-02-10 | Amira Pharmaceuticals, Inc. | Compounds as lysophosphatidic acid receptor antagonists |
| GB2474748B (en) | 2009-10-01 | 2011-10-12 | Amira Pharmaceuticals Inc | Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| GB2474120B (en) | 2009-10-01 | 2011-12-21 | Amira Pharmaceuticals Inc | Compounds as Lysophosphatidic acid receptor antagonists |
| JP2014513077A (ja) | 2011-04-05 | 2014-05-29 | アミラ ファーマシューティカルス，インコーポレーテッド | 線維症、疼痛、癌、ならびに呼吸器、アレルギー性、神経系または心血管疾患の治療に有用な３−または５−ビフェニル−４−イルイソキサゾールに基づく化合物 |
| CA2844982A1 (en) | 2011-08-15 | 2013-02-21 | Intermune, Inc. | Lysophosphatidic acid receptor antagonists |
| JP6139781B2 (ja) * | 2014-04-04 | 2017-05-31 | 国立大学法人大阪大学 | リゾリン脂質受容体を活性化する物質を含有する薬剤送達促進剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1036178A1 (de) * | 1997-12-30 | 2000-09-20 | Allelix Biopharmaceuticals Inc. | Identifizierung von lysolipid-rezeptoren zur förderung des entzundlichen antwortes |
| US6380177B1 (en) * | 1999-06-25 | 2002-04-30 | Atairgin Technologies, Inc. | LPA analogs as agonists of the Edg2 LPA receptor |
| AU2001232340A1 (en) * | 2000-02-18 | 2001-08-27 | Kirin Beer Kabushiki Kaisha | Novel isoxazole and thiazole compounds and use thereof as drugs |
| ATE380187T1 (de) * | 2000-03-17 | 2007-12-15 | Univ Tennessee Res Corp | Agonisten und antagonisten für den lpa-rezeptor und anwendungsmethoden |
| WO2002062389A1 (fr) * | 2001-02-08 | 2002-08-15 | Ono Pharmaceutical Co., Ltd. | Remedes pour des maladies urinaires contenant des agents de regulation du recepteur de lpa |
-
2002
- 2002-07-16 US US10/483,815 patent/US20040171582A1/en not_active Abandoned
- 2002-07-16 JP JP2003513596A patent/JPWO2003007991A1/ja not_active Withdrawn
- 2002-07-16 EP EP02746091A patent/EP1415667B1/de not_active Expired - Lifetime
- 2002-07-16 AT AT02746091T patent/ATE406915T1/de not_active IP Right Cessation
- 2002-07-16 WO PCT/JP2002/007213 patent/WO2003007991A1/ja active IP Right Grant
- 2002-07-16 DE DE60228732T patent/DE60228732D1/de not_active Expired - Fee Related
- 2002-07-16 ES ES02746091T patent/ES2312588T3/es not_active Expired - Lifetime
-
2008
- 2008-04-30 US US12/112,538 patent/US20080234230A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003007991A1 (fr) | 2003-01-30 |
| JPWO2003007991A1 (ja) | 2004-11-04 |
| US20080234230A1 (en) | 2008-09-25 |
| EP1415667A4 (de) | 2006-04-19 |
| ES2312588T3 (es) | 2009-03-01 |
| ATE406915T1 (de) | 2008-09-15 |
| US20040171582A1 (en) | 2004-09-02 |
| EP1415667B1 (de) | 2008-09-03 |
| EP1415667A1 (de) | 2004-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60228732D1 (de) | Mittel zur regulierung der sekretion von pankreassaft mit einem lpa-rezeptor-regler | |
| Bonnavion et al. | Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour | |
| Waagepetersen et al. | The GABA paradox: multiple roles as metabolite, neurotransmitter, and neurodifferentiative agent | |
| Katada et al. | Islet-activating protein. A modifier of receptor-mediated regulation of rat islet adenylate cyclase. | |
| WO2022006087A3 (en) | Systems and methods for heart valve leaflet repair | |
| BR0207325A (pt) | Métodos terapêuticos para doenças associadas com expressão diminuìda de gene de aop-1 ou aop-1 | |
| SI1474412T1 (sl) | Proizvodnja delta-9 tetrahidrokanabinola | |
| TW200618509A (en) | System, apparatus, computer program product and method for controlling terminal output power | |
| UA40587C2 (uk) | Метансульфонат (е)-3-[2-h-бутил-1{(4-карбоксифеніл)метил}-1н-імідазол-5-іл]-2-(2-тієніл)метил-2-пропенової кислоти, спосіб його одержання, фармацевтична композиція на його основі | |
| EP0955294A3 (de) | Imidazoalkensäure | |
| WO2002056645A3 (en) | Ballast for a discharge lamp | |
| WO2003051833A3 (en) | Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 | |
| ATE430589T1 (de) | Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen | |
| ATE70048T1 (de) | Selektive amidinierung von diaminen. | |
| BRPI0514638A (pt) | método para reservar serviço de sistema pt | |
| BR0105398A (pt) | Aparelho e método para o controle de operação de um compressor | |
| DE60036537D1 (de) | Zusammensetzungen zur gentherapie von diabetes | |
| Reibel et al. | Coenzyme A metabolism in pantothenic acid-deficient rats | |
| DE60031709D1 (de) | Zusammensetzungen für die elektroporation | |
| WO2003064452A3 (en) | Method for the preparation of highly branched polypeptides | |
| BR0116636A (pt) | Remédios para alìvio de distúrbios intestinais | |
| WO2003084565A3 (en) | Ve-ptp as regulator of ve-cadherin mediated processes or disorders | |
| JPS53122324A (en) | Power supply control system | |
| TWI256952B (en) | Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders | |
| EP1541171A4 (de) | Mittel zur behandlung von diabetes mellitus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |